A Novel Inhibitor of Glucose Uptake Sensitizes Cells to FAS-Induced Cell Death
3546 A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death Tabitha E. Wood,1,2 Shadi Dalili,1,2 transport as a mechanism to sensitize cells to death Craig D. Simpson,1 Rose Hurren,1 Xinliang Mao,1 receptor stimuli. Thus, fasentin is a novel inhibitor of Fernando Suarez Saiz,1 Marcela Gronda,1 glucose transport that blocks glucose uptake and high- Yanina Eberhard,1 Mark D. Minden,1 Philip J. Bilan,3 lights a new mechanism to sensitize cells to death ligands. Amira Klip,3 Robert A. Batey,2 [Mol Cancer Ther 2008;7(11):3546–55] and Aaron D. Schimmer1 1Princess Margaret Hospital, Ontario Cancer Institute; Introduction 2Department of Chemistry, University of Toronto; 3Cell Biology Resistance to stimuli of the death receptor pathway of Program, Hospital for Sick Children, Toronto, Ontario, Canada caspase activation can render malignant cells resistant to chemotherapy, immune surveillance, and anchorage-inde- Abstract pendent cell death, a process termed anoikis (1, 2). In addition, such resistance would also limit the therapeutic Evasion of death receptor ligand-induced apoptosis is an utility of agonistic monoclonal antibodies targeting tumor important contributor to cancer development and progres- necrosis factor (TNF) apoptosis-inducing ligand receptors sion. Therefore, molecules that restore sensitivity to death that are now in clinical trial (3). Therefore, small molecules receptor stimuli would be important tools to better that restore sensitivity of tumor cells to TNF family death understand this biological pathway and potential leads receptors would be useful probes to understand this for therapeutic adjuncts. Previously, the small-molecule pathway and potentially useful therapeutic adjuncts for N-[4-chloro-3-(trifluoromethyl)phenyl]-3-oxobutanamide the treatment of malignancy.
[Show full text]